Please assess the completion status of the following clinical trial:

Trial Title: Ursodeoxycholic Acid in C. Difficile Infection

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Completion of a course of antibiotic treatment for C. difficile infection within the previous 7 days~Exclusion Criteria:~* • Pregnant or Breast-feeding~  * Gall bladder inflammation~ * Frequent episodes of biliary colic~ * Occlusion of the common bile duct or cystic duct~ * Active small intestinal inflammation~ * Previous resection of distal small intestine~ * Treatment with bile salt binding agents, ciclosporin or ciprofloxacin~ * Diarrhoea (from any cause) at study initiation~ * hypersensitivity to bile acids or any excipient of the formulation~ * Life expectancy less than 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ursodeoxycholic acid (Type: EXPERIMENTAL): Only one arm - subjects receiving ursodeoxycholic acid

Based on this trial design, predict the completion outcome and termination type (if applicable).